Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia

Jeffrey R Bishop1,2, Mani N Pavuluri21Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA; 2Department of Psychiatry, Pediatric Mood Disorders Program and Center for Cognitive Medicine, University of Illinois at Chicago College of Medicine, Chicag...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jeffrey R Bishop, Mani N Pavuluri
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/114fb8b9e4014c84a4a5f1d80a3208a2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:114fb8b9e4014c84a4a5f1d80a3208a2
record_format	dspace
spelling	oai:doaj.org-article:114fb8b9e4014c84a4a5f1d80a3208a22021-12-02T00:54:47ZReview of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia1176-63281178-2021https://doaj.org/article/114fb8b9e4014c84a4a5f1d80a3208a22008-03-01T00:00:00Zhttp://www.dovepress.com/review-of-risperidone-for-the-treatment-of-pediatric-and-adolescent-bi-a996https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Jeffrey R Bishop1,2, Mani N Pavuluri21Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA; 2Department of Psychiatry, Pediatric Mood Disorders Program and Center for Cognitive Medicine, University of Illinois at Chicago College of Medicine, Chicago, IL, USAAbstract: Risperidone is a commonly used medication for the treatment of bipolar disorder and schizophrenia in children and adolescents. It has been studied as a monotherapy treatment in early onset schizophrenia and as both monotherapy and combination therapy for pediatric bipolar disorder. Studies to date indicate that risperidone is an effective treatment for positive and negative symptoms of schizophrenia and mania symptoms of bipolar disorder. In young patient populations, side effects such as weight gain, extrapyramidal side effects, and prolactin elevation require consideration when evaluating the risk benefit ratio for individual patients. Here we review published studies of risperidone for the treatment of bipolar disorder and schizophrenia in children and adolescents to provide practitioners with an overview of published data on the efficacy and safety of risperidone in these patient populations.Keywords: risperidone, bipolar disorder, schizophrenia, children, adolescents Jeffrey R BishopMani N PavuluriDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2008, Iss Issue 1, Pp 55-68 (2008)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Jeffrey R Bishop Mani N Pavuluri Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
description	Jeffrey R Bishop1,2, Mani N Pavuluri21Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA; 2Department of Psychiatry, Pediatric Mood Disorders Program and Center for Cognitive Medicine, University of Illinois at Chicago College of Medicine, Chicago, IL, USAAbstract: Risperidone is a commonly used medication for the treatment of bipolar disorder and schizophrenia in children and adolescents. It has been studied as a monotherapy treatment in early onset schizophrenia and as both monotherapy and combination therapy for pediatric bipolar disorder. Studies to date indicate that risperidone is an effective treatment for positive and negative symptoms of schizophrenia and mania symptoms of bipolar disorder. In young patient populations, side effects such as weight gain, extrapyramidal side effects, and prolactin elevation require consideration when evaluating the risk benefit ratio for individual patients. Here we review published studies of risperidone for the treatment of bipolar disorder and schizophrenia in children and adolescents to provide practitioners with an overview of published data on the efficacy and safety of risperidone in these patient populations.Keywords: risperidone, bipolar disorder, schizophrenia, children, adolescents
format	article
author	Jeffrey R Bishop Mani N Pavuluri
author_facet	Jeffrey R Bishop Mani N Pavuluri
author_sort	Jeffrey R Bishop
title	Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
title_short	Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
title_full	Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
title_fullStr	Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
title_full_unstemmed	Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
title_sort	review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
publisher	Dove Medical Press
publishDate	2008
url	https://doaj.org/article/114fb8b9e4014c84a4a5f1d80a3208a2
work_keys_str_mv	AT jeffreyrbishop reviewofrisperidoneforthetreatmentofpediatricandadolescentbipolardisorderandschizophrenia AT maninpavuluri reviewofrisperidoneforthetreatmentofpediatricandadolescentbipolardisorderandschizophrenia
_version_	1718403360800899072

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia

Ejemplares similares